Emerging as a potent anticancer treatment, subcellular targeted cancer therapy has drawn
increasing attention, bringing great opportunities for clinical application. Here, two targeting …

Multimodal medical data fusion has emerged as a transformative approach in smart
healthcare, enabling a comprehensive understanding of patient health and personalized …

Over the past 15 years, rapid progress has been made in developmental therapeutics,
especially regarding the use of matched targeted therapies against specific oncogenic …

PURPOSE Profiling of circulating tumor DNA (ctDNA) is increasingly adopted in the
management of solid tumors, concurrent with increased availability of more comprehensive …

Cancer management is major concern of health organizations and viral cancers account for
approximately 15.4% of all known human cancers. Due to large number of patients, efficient …

A growing number of druggable targets and national initiatives for precision oncology
necessitate broad genomic profiling for many cancer patients. Whole exome sequencing …

Personalized treatment strategies for cancer frequently rely on the detection of genetic
alterations which are determined by molecular biology assays. Historically, these processes …

Background Predictive biomarkers are essential for selecting the best therapeutic strategy in
patients with cancer. The International Quality Network for Pathology, the European Cancer …

The last decade has seen rapid progress in the use of genomic tests, including gene panels,
whole‐exome sequencing, and whole‐genome sequencing, in research and clinical cancer …

Science has made remarkable advances in understanding the molecular basis of disease,
generating new and effective rationally-designed treatments at an accelerating rate …